/ News
Thomson Reuters Predicts Nobel Laureates
With just two weeks until the recipients of some of the world’s most coveted research prizes are named, Thomson Reuters is releasing its picks for 2011 Thomson Reuters Citation Laureates – researchers likely to be in contention for Nobel honors.
Each year, Thomson Reuters uses data from its research solution, Web of Knowledge™, to quantitatively determine the most influential researchers in the Nobel categories of Physiology or Medicine, Physics, Chemistry, and Economics. Based on a thorough review of citations to their works, the company names these high-impact researchers as Thomson Reuters Citation Laureates and predicts them to be Nobel Prize winners, either this year or in the near future.
Thomson Reuters is the only organization to use quantitative data to make annual predictions of Nobel Prize winners. Since 2002, 21 Citation Laureates have gone on to win Nobel Prizes.
“In the scientific community, citations, when analyzed and counted, can serve as another form of peer review,” said David Pendlebury, Citation Analyst, Research Services, Thomson Reuters. "The more cited a scientist is, the more well-respected the author tends to be amongst his or her peers, which can be a predictor of awards like the Nobel Prize. Thomson Reuters Citation Laureates are chosen through a thoughtful assessment of citation counts and high-impact papers as well as consideration of discoveries or themes that the Nobel Committee may deem worthy of recognition.”
The Thomson Reuters Citation Laureates typically rank among the top one-tenth of one percent (0.1%) of researchers in their fields, based on citations of their published papers over the last two or three decades.
This year, 18 of the 24 Citation Laureates hail from American institutions; researchers from Austria, Australia, Canada, France, Germany, and Japan also appear among the 2011 picks.
For detailed information about each of the Citation Laureates, including their areas of study, and to read about previously named Citation Laureates who are still in the running for a Nobel Prize, visit the Thomson Reuters Citation Laureates website at science.thomsonreuters.com/nobel/.
Up to the minute news on all things Nobel is available by following@nobelcitings on Twitter.com. Facebook users are also encouraged to submit their guesses for the 2011 Nobel Prize winners and contribute to general Nobel discussion on the Citation Laureates Facebook page, which replaces the previous Thomson Reuters online forum.
The 2011 Thomson Reuters Citation Laureates by Nobel Prize category are:
Chemistry
Allen J. Bard
Hackerman-Welch Regents Chair in Chemistry and Director of the Center for Electrochemistry, Department of Chemistry and Biochemistry, University of Texas at Austin, Austin TX, USA
For the development and application of scanning electrochemical microscopy
Martin Karplus
Theodore William Richards Emeritus Professor of Chemistry, Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA USA and Director, Laboratory of Biophysical Chemistry, ISIS, Louis Pasteur University, Strasbourg, France
For pioneering simulations of the molecular dynamics of biomolecules
Jean M. J. Fréchet
Professor of Chemistry and of Chemical Engineering and Henry Rapoport Chair of Organic Chemistry, Department of Chemistry, University of California Berkeley, Berkeley CA USA, and Vice President of Research, King Abdullah University of Science and Technology, Thuwal, Kingdom of Saudi Arabia
-and-
Donald A. Tomalia
Distinguished Professor and Research Scientist, Department of Chemistry. and Director of the National Dendrimer and Nanotechnology Center, Central Michigan University, Mount Pleasant, MI USA. Also, Chief Scientific Officer, Dendritic Nanotechnologies, Inc., Mount Pleasant, MI USA
-and-
Fritz Vogtle
Emeritus Professor, Kekulé Institute for Organic Chemistry and Biochemistry, University of Bonn (Rheinische Friedrich-Wilhelms-Universität Bonn), Bonn Germany
For the invention and development of dendritic polymers
Economics
Douglas W. Diamond
Merton H. Miller Distinguished Service Professor of Finance, Booth School of Business, University of Chicago, Chicago, IL USA
For his analysis of financial intermediation and monitoring
Anne O. Krueger
Professor of International Economics, Paul H. Nitze School of Advanced International Studies, Johns Hopkins University, Washington, DC USA
-and-
Gordon Tullock
Professor Emeritus of Law and Economics, George Mason University School of Law, Arlington, VA USA
For their description of rent-seeking behavior and its implications
Jerry A. Hausman
John and Jennie S. MacDonald Professor, Department of Economics, Massachusetts Institute of Technology, Cambridge, MA USA
-and-
Halbert L. White, Jr.
Chancellor’s Associates Distinguished Professor of Economics, Department of Economics, University of California San Diego, La Jolla, CA USA
For their contributions to econometrics, specifically the Hausman specification test and the White standard errors test
Physics
Alain Aspect
CNRS Distinguished Scientist and Head of the Atom Optics Group, Laboratoire Charles Fabry, Institut d’Optique, Palaiseau France. Also, Professor at the Institut d’Optique and at the Ecole Polytechnique France
-and-
John F. Clauser
Research Physicist, J.F. Clauser & Associates, Walnut Creek, CA USA
-and-
Anton Zeilinger
Full Professor of Experimental Physics, University of Vienna, and Scientific Director, Institute of Quantum Optics and Quantum Information, Austrian Academy of Sciences, Vienna Austria
For their tests of Bell’s inequalities and research on quantum entanglement
Sajeev John
University Professor of Physics and Canada Research Chair, Department of Physics, University of Toronto, Toronto, Ontario Canada
-and-
Eli Yablonovitch
Professor and James and Katherine Lau Chair in Engineering, Department of Electrical Engineering and Computer Sciences, University of California Berkeley, Berkeley, CA USA
For their invention and development of photonic band gap materials
Hideo Ohno
Professor of the Laboratory for Nanoelectronics and Spintronics, Research Institute of Electrical Communication, and Director of the Center for Spintronics Integrated Systems, Tohoku University, Sendai Japan
For contributions to ferromagnetism in diluted magnetic semiconductors
Physiology or Medicine
Brian J. Druker
Professor of Medicine, JELD-WEN Chair of Leukemia Research, and Director, OHSU Knight Cancer Institute, Oregon Health & Science University, Portland OR USA. Also, Howard Hughes Medical Institute Investigator
-and-
Nicholas B. Lydon
Founder, Granite Biopharma, LLC, Jackson Hole, WY USA; Co-founder and Director, AnaptysBio, San Diego, CA USA; and Co-founder and Director, Blueprint Medicines, Cambridge, MA USA
-and-
Charles L. Sawyers
Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis, Memorial Sloan-Kettering Cancer Center, New York, NY USA. Also, Howard Hughes Medical Institute Investigator
For their development of imatinib and dasatinib, revolutionary, targeted treatments for chronic myeloid leukemia
Robert S. Langer
David H. Koch Institute Professor, Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA USA
-and-
Joseph P. Vacanti
John Homans Professor of Surgery, Harvard Medical School; Surgeon-in-Chief and Chief of the Department of Pediatric Surgery and Director of the Laboratory for Tissue Engineering and Organ Fabrication, Massachusetts General Hospital, Boston, MA USA
For their pioneering research in tissue engineering and regenerative medicine
Jacques F. A. P. Miller
Emeritus Professor, Walter and Eliza Hall Institute of Medical Research and the University of Melbourne, Parkville, Melbourne, Australia
For his discovery of the function of the thymus and the identification of T cells and B cells in mammalian species
-with-
Robert L. Coffman
Vice President and Chief Scientific Officer, Dynavax Technologies, Berkeley, CA USA
-and-
Timothy R. Mosmann
Professor, Department of Microbiology and Immunology, and Michael and Angela Pichichero Director in the David H. Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, University of Rochester, Rochester, NY USA
For their discovery of two types of T lymphocytes, TH1 and TH2, and their role in regulating host immune response
Source: http://thomsonreuters.com/content/press_room/science/2011-citation-laureates
/ About us
Founded by Russian entrepreneur Dmitry Itskov in February 2011 with the participation of leading Russian specialists in the field of neural interfaces, robotics, artificial organs and systems.
The main goals of the 2045 Initiative: the creation and realization of a new strategy for the development of humanity which meets global civilization challenges; the creation of optimale conditions promoting the spiritual enlightenment of humanity; and the realization of a new futuristic reality based on 5 principles: high spirituality, high culture, high ethics, high science and high technologies.
The main science mega-project of the 2045 Initiative aims to create technologies enabling the transfer of a individual’s personality to a more advanced non-biological carrier, and extending life, including to the point of immortality. We devote particular attention to enabling the fullest possible dialogue between the world’s major spiritual traditions, science and society.
A large-scale transformation of humanity, comparable to some of the major spiritual and sci-tech revolutions in history, will require a new strategy. We believe this to be necessary to overcome existing crises, which threaten our planetary habitat and the continued existence of humanity as a species. With the 2045 Initiative, we hope to realize a new strategy for humanity's development, and in so doing, create a more productive, fulfilling, and satisfying future.
The "2045" team is working towards creating an international research center where leading scientists will be engaged in research and development in the fields of anthropomorphic robotics, living systems modeling and brain and consciousness modeling with the goal of transferring one’s individual consciousness to an artificial carrier and achieving cybernetic immortality.
An annual congress "The Global Future 2045" is organized by the Initiative to give platform for discussing mankind's evolutionary strategy based on technologies of cybernetic immortality as well as the possible impact of such technologies on global society, politics and economies of the future.
Future prospects of "2045" Initiative for society
2015-2020
The emergence and widespread use of affordable android "avatars" controlled by a "brain-computer" interface. Coupled with related technologies “avatars’ will give people a number of new features: ability to work in dangerous environments, perform rescue operations, travel in extreme situations etc.
Avatar components will be used in medicine for the rehabilitation of fully or partially disabled patients giving them prosthetic limbs or recover lost senses.
2020-2025
Creation of an autonomous life-support system for the human brain linked to a robot, ‘avatar’, will save people whose body is completely worn out or irreversibly damaged. Any patient with an intact brain will be able to return to a fully functioning bodily life. Such technologies will greatly enlarge the possibility of hybrid bio-electronic devices, thus creating a new IT revolution and will make all kinds of superimpositions of electronic and biological systems possible.
2030-2035
Creation of a computer model of the brain and human consciousness with the subsequent development of means to transfer individual consciousness onto an artificial carrier. This development will profoundly change the world, it will not only give everyone the possibility of cybernetic immortality but will also create a friendly artificial intelligence, expand human capabilities and provide opportunities for ordinary people to restore or modify their own brain multiple times. The final result at this stage can be a real revolution in the understanding of human nature that will completely change the human and technical prospects for humanity.
2045
This is the time when substance-independent minds will receive new bodies with capacities far exceeding those of ordinary humans. A new era for humanity will arrive! Changes will occur in all spheres of human activity – energy generation, transportation, politics, medicine, psychology, sciences, and so on.
Today it is hard to imagine a future when bodies consisting of nanorobots will become affordable and capable of taking any form. It is also hard to imagine body holograms featuring controlled matter. One thing is clear however: humanity, for the first time in its history, will make a fully managed evolutionary transition and eventually become a new species. Moreover, prerequisites for a large-scale expansion into outer space will be created as well.
Key elements of the project in the future
• International social movement
• social network immortal.me
• charitable foundation "Global Future 2045" (Foundation 2045)
• scientific research centre "Immortality"
• business incubator
• University of "Immortality"
• annual award for contribution to the realization of the project of "Immortality”.